https://zelirahope.com/news/zelira-june-quarterly-update/2020-10-02T18:09:23+00:00https://zelirahope.com/news/new-data-sparks-hope-in-using-medical-cannabis-for-autism/2020-08-11T03:10:53+00:00https://zelirahope.com/news/dr-oludare-odumosu-digs-deep-into-questions-on-cannabis-medicine-going-forward/2020-08-11T03:08:14+00:00https://zelirahope.com/news/zelira-therapeutics-expands-hope-distribution-in-the-u-s-a/2020-08-11T03:07:43+00:00https://zelirahope.com/news/zelira-therapeutics-will-expand-hope-distribution-to-us-state-of-louisiana/2022-08-03T15:34:30+00:00https://zelirahope.com/news/a-natural-history-study-of-medical-cannabis-consumption-in-pediatric-autism-in-the-united-states/2022-08-03T15:37:06+00:00https://zelirahope.com/news/hope-1-demonstrates-improvements-in-clinical-global-impression-cgi-in-patients-with-autism-spectrum-disorder/2022-08-03T15:41:07+00:00https://zelirahope.com/news/autism-spectrum-disorder-patients-demonstrate-improvements-in-clinical-global-impression-whilst-on-hope-1/2022-08-04T17:13:30+00:00